source
- FDA panel questions effectiveness of Grail's early-cancer detection testFDA's Molecular and Clinical Genetics Panel and agency officials raised concerns about Grail's next-generation sequencing test designed to detect multiple cancers early in adults over 50. The advi…
- World's first personalized gene-editing therapy costs $1.65 million per patient, project director saysAt a rare disease conference in Oxford, Fyodor Urnov disclosed that the world's first therapy designed to correct an individual’s unique genetic mutation cost $1.65 million to produce. The treatme…